Liang kan

Dr. Liang kan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YLYibin Lin
Yibin Lin
YSYifu Song
Yifu Song
YZYaochuan Zhang
Yaochuan Zhang
XLXiaodong Li
Xiaodong Li
LKLiang kan
Liang kan
SHSheng Han
Sheng Han
Recent breakthroughs in tumor immunotherapy have confirmed the capacity of the immune system to fight several cancers. The effective means of treating cancer involves accelerating the death of tumor cells and improving patient immunity. Dynamic changes in the tumor immune microenvironment alter the actual effects of anti-tumor drug production and may trigger favorable or unfavorable immune responses by modulating tumor-infiltrating lymphocytes. Notably, CD8+ T cells are one of the primary tumor-infiltrating immune cells that provide anti-tumor response. Tumor cells and tumor stem cells will resist or evade destruction through various mechanisms as CD8+ T cells exert their anti-tumor function. This paper reviews the research on the regulation of tumor development and prognosis by cancer stem cells that directly or indirectly alter the role of tumor-infiltrating CD8+ T cells. We also discuss related immunotherapy strategies.

1 November 2021 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
LCLihua Chang
Lihua Chang
LKLiang kan
Liang kan
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease of articular joint damage and elevated synovial hyperplasia. Abnormal proliferation, invasion inflammatory response of rheumatoid fibroblast-like synoviocytes (RA-FLS) play a critical role in RA progression. Mesenchymal stem cell (MSC)–derived exosomal circular RNAs are promising therapeutic manner for disease treatment. This work aimed to decipher the role of exosomal circFBXW7 in RA. Methods: The expression of circFBXW7, miR-216a-3p, and HDAC4 were detected in clinical RA samples. The RA rat model was established. Isolation and identification of exosomes from MSCs was conducted. The effects of exosomal circFBXW7 on RA was evaluated by qPCR, CCK-8, transwell assays, flow cytometry, Western blotting, ELISA, and immunohistochemical assay. Interaction between miR-216a-3p and circFBXW7 or HDAC4 was determined by luciferase reporter gene assay and RNA pulldown. Results: Exosomal circFBXW7 treatment suppressed proliferation, migration and inflammatory response of RA-FLSs and damage of RA model. CircFBXW7 could directly sponge miR-216a-3p to upregulate the expression of HDAC4. Inhibition of HDAC4 or upregulation of miR-216a-3p abolished the therapeutic function of exosomal circFBXW7. Our data demonstrated that circFBXW7 and HDAC4 were decreased, and miR-216a-3p was elevated in clinical RA sample compared with healthy samples. Conclusion: We concluded that MSC-derived exosomal circFBXW7 suppressed proliferation, migration and inflammatory response of RA-FLSs and damage of RA rats via sponging miR-216a-3p and release the activation of HDAC4. These findings may provide a novel therapeutic target for RA.

20 October 2021 in Journal of Radiation Research and Applied Sciences
Verified
Journal Article
Open access
ZGZheng Gong
Zheng Gong
LKLiang kan
Liang kan
Kidney tumors are the second most frequent urology tumors. They are of many types, mostly existing as malignant tumors. In order to improve the accuracy of segmentation and classification of kidney tumors, this paper proposes to build a model of simultaneous segmentation and classification of kidney tumors based on convolutional neural networks to assist medical experts in diagnosis. A two-task neural network 2D SCNet is proposed by combining kidney tumor segmentation and classification. Based on our proposed framework, classification can feed back the global contextual information of the network, and segmentation can make the network focus on local features and regions of interest (ROI). Both tasks jointly promote network feature learning and both increase each other’s prior information. The combination of segmentation and classification of 2D SCNet can achieve an accuracy rate of 99.5% in both benign and malignant classification. The results of the ‘2D SCNet + three-label’ segmentation reached Dice coefficients of 0.946 and 0.846, respectively. Compared with PSPNet, our network kidney and tumor segmentation results are improved by 4.9% and 5.0%, respectively, which shows that the addition of classification module is beneficial to the learning of segmentation network. From the cross-validation results, we can see that 2D SCNet and the two-step segmentation strategy can obtain better results in the segmentation and classification tasks of kidney tumors. The base network of 2D SCNet can extract networks for any feature. This paper compares Res Net50+ PPM and Dense Net as the results of segmentation and classification of the base network. Res Net50+ PPM obtains better results. 2D SCNet can help to segment and examine kidney tumors more efficiently and accurately.

2 September 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
GTGuofeng Tian
Guofeng Tian
YSYifu Song
Yifu Song
YZYaochuan Zhang
Yaochuan Zhang
LKLiang kan
Liang kan
AHA-na Hou
A-na Hou
SHSheng Han
Sheng Han
Glioma represents the most prevalent primary tumors of the central nervous system, originating from glial cells. Cancer stem cells have the ability to extensively proliferate, self-renew, and form colonies, which contribute to tumorigenesis. Studies have found a population of cells within glioblastoma exhibiting characteristics similar to those of cancer cells, termed glioma stem cells (GSCs). GSCs have two distinct phenotypes: mesenchymal subtype (MES) and proneural subtype (PN). Despite the vital role of these subtypes in glioma biology, there is a significant lack of comprehensive reviews focusing on the regulatory mechanisms underlying each phenotype.This review integrates emerging insights into the regulatory mechanisms underlying GSCs plasticity, with dedicated analysis of novel pathways governing PN and MES phenotypes and their dynamic transition. By examining these critical elements, we aim to contribute to the development of novel therapeutic strategies in the ongoing fight against gliomas.

6 December 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
RWRun Wang
Run Wang
XHXiaodi Han
Xiaodi Han
CXCheng Xie
Cheng Xie
QZQinghua Zhang
Qinghua Zhang
LKLiang kan
Liang kan
SHSheng Han
Sheng Han
Background: Pituitary adenomas (PAs) present with clinical features such as neuroendocrine abnormalities and mass effects, common in the general morbidity population. However, in elderly patients, the disease progression renders some clinical features difficult to detect and identify in time. Consequently, elderly patients with PAs are often not identified and receive sufficient intervention on time to achieve a satisfactory outcome.Methods: Clinical data were collected from 114 consecutive patients older than 70 years with PAs who had undergone surgery. Based on the average age, the patients were categorized into a younger group and an elder group, and were statistically analyzed and compared.Results: Sixty-five males (57.0%) and 49 females (43.0%) were included in the study, with an average age of 73.2 years. Their common preoperative symptoms included vision impairment, followed by headache and vomiting, and visual field defect. The milder the preoperative visual impairment, the greater the possibility of post-operative visual improvement (P=0.001). The tumors were primarily non-functional pituitary adenomas (NFPAs, 73.7%), with a high degree of suprasellar invasion but a low degree of parasellar invasion (P<0.0001). For further analysis, based on the average age, we categorized the patients into younger (age< 73 years, 59 cases) and elder (age≥ 73 years, 55 cases) groups. The elder group was more likely to have preoperative vision impairment problems (P=0.044), whilst post-operative visual improvement was worse (P=0.001). The elder group also had a more severe suprasellar invasion (P=0.009), with a higher proportion of NFPA than the younger group (P=0.006). Compared to the younger group, the tumors in the elder group were larger (P=0.039), and had a higher rate of apoplexy (P=0.039), and were more likely to have comorbid postoperative complications (P=0.031), such as fever and cerebrospinal fluid (CSF) leakage, compared to the younger group.Conclusions: Elderly patients with PA had specific clinical characteristics. Their relatively worse pre- and post-operative conditions and intraoperative findings illustrated the need for early surgery.

1 January 2023 in Acta of Bioengineering and Biomechanics
Verified
Journal Article
Closed access
RARunZe An
RunZe An
LKLiang kan
Liang kan
WLWentao Liu
Wentao Liu
WTWenmin Tang
Wenmin Tang
ZZZhan Peng Zhao
Zhan Peng Zhao
Purpose: Curcumin and icariin have multiple pharmacological effects and are widely used in various fields, but their short half-life, poor bioavailability and low water solubility greatly limit their application in clinical medicine. Poly(lactide-co-glycolide) (PLGA) loaded microspheres not only solve these problems, but also have no toxicity in degradation. Methods: To verify whether PLGA drugloaded microspheres have good biocompatibility, the present experiments used the emulsification-solvent evaporation method to prepare PLGA drug-loaded microspheres and successfully performed the loading of curcumin and icariin. Results: The scanning electron microscopy showed that the particle sizes of the PLGA microspheres were 2-15 lim, icariin/PLGA microspheres were 3-22 lim and curcumin/PLGA microspheres were 5-30 lim. Moreover, the surface of the microspheres was smooth and spherical. Furthermore, the drug loading and encapsulation rate were good. In vitro experiments revealed that the prepared PLGA microspheres were safe and nontoxic, and that they could release drugs stably and slowly. Moreover, their proliferation ability was unaffected after inoculation into bone marrow mesenchymal stem cells (BMSCs), and Alcian blue Staining was performed at last, demonstrating their biocompatibility and important applications in tissue engineering.